Factors associated with cytomegalovirus antigenemia in patients with rheumatic disease: A retrospective study-Reference-Cited by-同舟云学术

Factors associated with cytomegalovirus antigenemia in patients with rheumatic disease: A retrospective study

Published:2022-11 Issue:11 Volume:28 Page:1471-1477
ISSN:1341-321X
Container-title:Journal of Infection and Chemotherapy
language:en
Short-container-title:Journal of Infection and Chemotherapy

Author:

Ogata Hideyuki,Aoki Nobumasa,Nagano Kei,Hakamata Mariko,Bamba Yuuki,Shibata Satoshi,Koizumi Takeshi,Ohshima Yasuyoshi^ORCID,Watanabe Satoshi^ORCID,Moro Hiroshi^ORCID,Koya Toshiyuki,Kikuchi Toshiaki^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Pharmacology (medical),Microbiology (medical)

Reference39 articles.

1. Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments;Gandhi;Lancet Infect Dis,2004

2. High-level sensitivity of quantitative pp65 cytomegalovirus (CMV) antigenemia assay for diagnosis of CMV disease in aids patients and follow-up;Bek;J Clin Microbiol,1996

3. Cytomegalovirus reactivation in critically ill immunocompetent patients;Limaye;JAMA,2008

4. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study;Boeckh;Blood,1996

5. Cellular and molecular basis of the protective immune response to cytomegalovirus infection;Koszinowski;Curr Top Microbiol Immunol,1990

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review on cytomegalovirus in patients with autoimmune inflammatory rheumatic diseases: Prevalence, clinical spectrum, treatment, and antiviral prophylaxis;Proceedings of Singapore Healthcare;2024-01